These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1400 related articles for article (PubMed ID: 30135334)

  • 1. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.
    Kinoshita M; Yokote K; Arai H; Iida M; Ishigaki Y; Ishibashi S; Umemoto S; Egusa G; Ohmura H; Okamura T; Kihara S; Koba S; Saito I; Shoji T; Daida H; Tsukamoto K; Deguchi J; Dohi S; Dobashi K; Hamaguchi H; Hara M; Hiro T; Biro S; Fujioka Y; Maruyama C; Miyamoto Y; Murakami Y; Yokode M; Yoshida H; Rakugi H; Wakatsuki A; Yamashita S;
    J Atheroscler Thromb; 2018 Sep; 25(9):846-984. PubMed ID: 30135334
    [No Abstract]   [Full Text] [Related]  

  • 2. Women. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K;
    J Atheroscler Thromb; 2014; 21(4):291-5. PubMed ID: 24335044
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment A) lifestyle modification: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2013; 20(12):835-49. PubMed ID: 24172256
    [No Abstract]   [Full Text] [Related]  

  • 4. Comprehensive risk management for the prevention of cardiovascular disease: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -- 2012.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K;
    J Atheroscler Thromb; 2013; 20(7):603-15. PubMed ID: 23883545
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment B) drug therapy: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2013; 20(12):850-60. PubMed ID: 24335039
    [No Abstract]   [Full Text] [Related]  

  • 6. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K;
    J Atheroscler Thromb; 2013; 20(6):517-23. PubMed ID: 23665881
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetes mellitus. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2014; 21(2):93-8. PubMed ID: 24335040
    [No Abstract]   [Full Text] [Related]  

  • 8. Coronary artery disease. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2014; 21(2):86-92. PubMed ID: 24335038
    [No Abstract]   [Full Text] [Related]  

  • 9. Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2014; 21(2):82-5. PubMed ID: 24335037
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors of atherosclerotic diseases. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese.
    Teramoto T; Sasaki J; Ueshima H; Egusa G; Kinoshita M; Shimamoto K; Daida H; Biro S; Hirobe K; Funahashi T; Yokote K; Yokode M
    J Atheroscler Thromb; 2007 Dec; 14(6):267-77. PubMed ID: 18176013
    [No Abstract]   [Full Text] [Related]  

  • 11. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese.
    Teramoto T; Sasaki J; Ueshima H; Egusa G; Kinoshita M; Shimamoto K; Daida H; Biro S; Hirobe K; Funahashi T; Yokote K; Yokode M
    J Atheroscler Thromb; 2007 Apr; 14(2):45-50. PubMed ID: 17485887
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis of atherosclerosis. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K;
    J Atheroscler Thromb; 2014; 21(4):296-8. PubMed ID: 24335045
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2013; 20(10):733-42. PubMed ID: 23892529
    [No Abstract]   [Full Text] [Related]  

  • 14. [Guidelines -- substitute textbook guidelines for daily or limited use?].
    Maisch B; Dörr R
    Herz; 2009 Feb; 34(1):1-2. PubMed ID: 19214403
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipid Management in a Japanese Community:Attainment Rate of Target Set by the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012.
    Tada H; Kawashiri MA; Nohara A; Inazu A; Kobayashi J; Yasuda K; Mabuchi H; Yamagishi M; Hayashi K
    J Atheroscler Thromb; 2017 Mar; 24(3):338-345. PubMed ID: 27568728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Atherosclerotic Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: Controversies and Guidelines.
    Raggi P
    Can J Diabetes; 2020 Feb; 44(1):86-92. PubMed ID: 31594760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts).
    De Backer G; Ambrosioni E; Borch-Johnsen K; Brotons C; Cifkova R; Dallongeville J; Ebrahim S; Faergeman O; Graham I; Mancia G; Cats VM; Orth-Gomér K; Perk J; Pyörälä K; Rodicio JL; Sans S; Sansoy V; Sechtem U; Silber S; Thomsen T; Wood D;
    Atherosclerosis; 2004 Apr; 173(2):381-91. PubMed ID: 15195638
    [No Abstract]   [Full Text] [Related]  

  • 18. The 2013 ACC/AHA Cholesterol Management Guideline: Clearing the Confusion from Noncontroversial Components.
    Virani SS
    Tex Heart Inst J; 2016 Aug; 43(4):313-4. PubMed ID: 27547139
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline.
    Newman CB; Blaha MJ; Boord JB; Cariou B; Chait A; Fein HG; Ginsberg HN; Goldberg IJ; Murad MH; Subramanian S; Tannock LR
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32951056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
    Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G
    Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.